The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has
increased among the general population and chronic hepatitis B (CHB) patients worldwide …

Simple Summary Multifactorial diseases are caused by a combination of genetic and
environmental factors and various risk factors that accumulate with age. Cardiovascular …

Conclusions: In individuals with CMRF, the presence of steatotic liver disease (MASLD)
alone did not increase the risk of mortality, except in cases with more alcohol consumption …

Background The classification and nomenclature of non-alcoholic fatty liver disease
(NAFLD) has been the subject of ongoing debate in the medical community. Through the …

The gut is a fundamental organ in controlling human health. Recently, researches showed
that substances in the intestine can alter the course of many diseases through the intestinal …

Metabolic dysfunction-associated fatty liver disease (MAFLD) has now affected nearly one-
third of the global population and has become the number one cause of chronic liver …

Abstract Purpose of Review The objective of this manuscript is to examine the current
literature on the epidemiology of metabolic dysfunction-associated steatotic liver disease …

The silent obesity epidemic has led to the rising global prevalence of non-alcoholic fatty liver
disease (NAFLD). This metabolic burden is a growing public health concern as forecast …

Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2
diabetes mellitus (DM) are the most prevalent metabolic disorders globally. The numbers …

The metabolic syndrome, characterized by type 2 diabetes mellitus (T2DM), hypertension,
hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases …